Guselkumab is a human monoclonal antibody directed against interleukin 23 (IL23). Guselkumab is being used in the treatment of plaque psoriasis.

What can Sanquin do for you?

  • Measure drug levels of free drug in the serum using an validated ELISA.
  • Measure the immunogenicity of guselkumab.
  • Provide assay reagents or co-develop novel testing strategies.
  • Folllowing ISO, FDA/EMA, RUO guidelines.

Enquire about our drug level and ADA assays by emailing us at [email protected]